Logo image of ROVR.CA

ROVER CRITICAL MINERALS CORP (ROVR.CA) Stock Fundamental Analysis

TSX-V:ROVR - TSX Venture Exchange - CA77935R2072 - Common Stock - Currency: CAD

0.17  -0.01 (-5.56%)

Fundamental Rating

0

Taking everything into account, ROVR scores 0 out of 10 in our fundamental rating. ROVR was compared to 0 industry peers in the Unkown industry. ROVR may be in some trouble as it scores bad on both profitability and health. ROVR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ROVR had negative earnings in the past year.
In the past year ROVR has reported a negative cash flow from operations.
ROVR had negative earnings in each of the past 5 years.
ROVR had a negative operating cash flow in each of the past 5 years.
ROVR.CA Yearly Net Income VS EBIT VS OCF VS FCFROVR.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -1M -2M -3M

1.2 Ratios

Industry RankSector Rank
ROA -9.15%
ROE -10.61%
ROIC N/A
ROA(3y)-26.31%
ROA(5y)-31.84%
ROE(3y)-29.36%
ROE(5y)-38.02%
ROIC(3y)N/A
ROIC(5y)N/A
ROVR.CA Yearly ROA, ROE, ROICROVR.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100

1.3 Margins

ROVR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ROVR.CA Yearly Profit, Operating, Gross MarginsROVR.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

0

2. Health

2.1 Basic Checks

Compared to 1 year ago, ROVR has more shares outstanding
ROVR has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ROVR is higher compared to a year ago.
ROVR.CA Yearly Shares OutstandingROVR.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
ROVR.CA Yearly Total Debt VS Total AssetsROVR.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M

2.2 Solvency

ROVR has an Altman-Z score of -0.09. This is a bad value and indicates that ROVR is not financially healthy and even has some risk of bankruptcy.
A Debt/Equity ratio of 0.04 indicates that ROVR is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z -0.09
ROIC/WACCN/A
WACCN/A
ROVR.CA Yearly LT Debt VS Equity VS FCFROVR.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M

2.3 Liquidity

ROVR has a Current Ratio of 0.08. This is a bad value and indicates that ROVR is not financially healthy enough and could expect problems in meeting its short term obligations.
ROVR has a Quick Ratio of 0.08. This is a bad value and indicates that ROVR is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.08
Quick Ratio 0.08
ROVR.CA Yearly Current Assets VS Current LiabilitesROVR.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 78.47% over the past year.
EPS 1Y (TTM)78.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%78.34%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, ROVR will show a decrease in Earnings Per Share. The EPS will decrease by 0.00% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y0%
EPS Next 2Y0%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ROVR.CA Yearly EPS VS EstimatesROVR.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 -0.1 -0.2 -0.3 -0.4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ROVR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ROVR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ROVR.CA Price Earnings VS Forward Price EarningsROVR.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ROVR.CA Per share dataROVR.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ROVR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ROVER CRITICAL MINERALS CORP

TSX-V:ROVR (8/15/2025, 7:00:00 PM)

0.17

-0.01 (-5.56%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)04-25 2025-04-25
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners15.53%
Ins Owner ChangeN/A
Market Cap2.52M
Analysts80
Price Target6.32 (3617.65%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.52
P/tB 0.52
EV/EBITDA N/A
EPS(TTM)-0.07
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS0.32
TBVpS0.32
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.15%
ROE -10.61%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-26.31%
ROA(5y)-31.84%
ROE(3y)-29.36%
ROE(5y)-38.02%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.08
Quick Ratio 0.08
Altman-Z -0.09
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)78.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%78.34%
EPS Next Y0%
EPS Next 2Y0%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y69.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year12.5%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y75.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y75.87%
OCF growth 3YN/A
OCF growth 5YN/A